These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [The negative enrichment by immunomagnetic beads for tumor cells from malignant pleural effusions]. Yang JJ; Xu XX; Min LF; Lin P; Qian GS Zhonghua Jie He He Hu Xi Za Zhi; 2012 Sep; 35(9):673-8. PubMed ID: 23158070 [TBL] [Abstract][Full Text] [Related]
3. Young investigator challenge: The utility of GATA3 immunohistochemistry in the evaluation of metastatic breast carcinomas in malignant effusions. Lew M; Pang JC; Jing X; Fields KL; Roh MH Cancer Cytopathol; 2015 Oct; 123(10):576-81. PubMed ID: 26465236 [TBL] [Abstract][Full Text] [Related]
4. Wilms tumor 1/cytokeratin dual-color immunostaining reveals distinctive staining patterns in metastatic melanoma, metastatic carcinoma, and mesothelial cells in pleural fluids: an effective first-line test for the workup of malignant effusions. Conner JR; Cibas ES; Hornick JL; Qian X Cancer Cytopathol; 2014 Aug; 122(8):586-95. PubMed ID: 25044880 [TBL] [Abstract][Full Text] [Related]
5. VEGF and sVEGFR-1 in malignant pleural effusions: association with survival and pleurodesis outcomes. Hooper CE; Elvers KT; Welsh GI; Millar AB; Maskell NA Lung Cancer; 2012 Aug; 77(2):443-9. PubMed ID: 22487430 [TBL] [Abstract][Full Text] [Related]
6. Altered expression and activation of the nerve growth factor receptors TrkA and p75 provide the first evidence of tumor progression to effusion in breast carcinoma. Davidson B; Reich R; Lazarovici P; Ann Flørenes V; Nielsen S; Nesland JM Breast Cancer Res Treat; 2004 Jan; 83(2):119-28. PubMed ID: 14997042 [TBL] [Abstract][Full Text] [Related]
7. D2-40 is not a specific marker for cells of mesothelial origin in serous effusions. Bassarova AV; Nesland JM; Davidson B Am J Surg Pathol; 2006 Jul; 30(7):878-82. PubMed ID: 16819331 [TBL] [Abstract][Full Text] [Related]
8. The value of ThinPrep and cytospin preparation in pleural effusion cytological diagnosis of mesothelioma and adenocarcinoma. Ylagan LR; Zhai J Diagn Cytopathol; 2005 Mar; 32(3):137-44. PubMed ID: 15690333 [TBL] [Abstract][Full Text] [Related]
9. Detection of hyperdiploid malignant cells in pleural effusions with chromosome-specific probes and fluorescence in situ hybridization. Johnson TM; Kuffel DG; Dewald GW Mayo Clin Proc; 1996 Jul; 71(7):643-8. PubMed ID: 8656705 [TBL] [Abstract][Full Text] [Related]
10. Expression, correlation, and prognostic value of TRAF2 and TRAF4 expression in malignant plural effusion cells in human breast cancer. Zhao ZJ; Ren HY; Yang F; Wang J; Wu GP; Mi XY Diagn Cytopathol; 2015 Nov; 43(11):897-903. PubMed ID: 26331901 [TBL] [Abstract][Full Text] [Related]
11. Demonstration of estrogen and progesterone receptors as well as Ki-67 and p-145 antigens in single tumor cells from blood and pleural effusions using a slide assay. Hirsch FW; Deibert P; Busch H; Löhr GW; Bross KJ J Cancer Res Clin Oncol; 1991; 117(3):217-22. PubMed ID: 2033090 [TBL] [Abstract][Full Text] [Related]
12. Immunocytochemistry and ELISA quantitation of mucin for diagnosis of malignant pleural effusions. Yang PC; Luh KT; Kuo SH; Wu CW Am Rev Respir Dis; 1992 Dec; 146(6):1571-5. PubMed ID: 1456577 [TBL] [Abstract][Full Text] [Related]
13. Malignant mesothelioma: immunohistochemistry and DNA ploidy analysis as methods to differentiate mesothelioma from benign reactive mesothelial cell proliferation and adenocarcinoma in pleural and peritoneal effusions. Friedman MT; Gentile P; Tarectecan A; Fuchs A Arch Pathol Lab Med; 1996 Oct; 120(10):959-66. PubMed ID: 12046609 [TBL] [Abstract][Full Text] [Related]
14. Thoracoscopic collagen pleurodesis in the treatment of malignant pleural effusions. Akopov AL; Egorov VI; Varlamov VV; Levashev YN; Artioukh DY Eur J Cardiothorac Surg; 2005 Nov; 28(5):750-3. PubMed ID: 16198593 [TBL] [Abstract][Full Text] [Related]
15. Cytoplasmic and nuclear estradiol and progesterone receptors in human endometrium. Bayard F; Damilano S; Robel P; Baulieu EE J Clin Endocrinol Metab; 1978 Apr; 46(4):635-48. PubMed ID: 755048 [TBL] [Abstract][Full Text] [Related]
16. Early diagnosis of mesothelioma in serous effusions using AgNOR analysis. Pomjanski N; Motherby H; Buckstegge B; Knops K; Rohn BL; Böcking A Anal Quant Cytol Histol; 2001 Apr; 23(2):151-60. PubMed ID: 11332082 [TBL] [Abstract][Full Text] [Related]
18. Binding capacities of two immunomodulatory lectins, carrier-immobilized glycoligands and steroid hormones in lung cancer and the concentration of nitrite/nitrate in pleural effusions. Timoshenko AV; Kayser K; Kaltner H; André S; Gabius HJ Lung Cancer; 1996 Feb; 14(1):75-84. PubMed ID: 8696722 [TBL] [Abstract][Full Text] [Related]
19. T-helper type 1/T-helper type 2 balance in malignant pleural effusions compared to tuberculous pleural effusions. Okamoto M; Hasegawa Y; Hara T; Hashimoto N; Imaizumi K; Shimokata K; Kawabe T Chest; 2005 Dec; 128(6):4030-5. PubMed ID: 16354877 [TBL] [Abstract][Full Text] [Related]
20. Carbohydrate antigen expression in primary tumors, metastatic lesions, and serous effusions from patients diagnosed with epithelial ovarian carcinoma: evidence of up-regulated Tn and Sialyl Tn antigen expression in effusions. Davidson B; Berner A; Nesland JM; Risberg B; Kristensen GB; Tropé CG; Bryne M Hum Pathol; 2000 Sep; 31(9):1081-7. PubMed ID: 11014575 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]